
    
      Prospective, multi-center study enrolling a minimum of 20 up to a maximum of 80 patients at
      up to six investigational sites in the United States and European Union. Patients meeting
      eligibility criteria for TAVR will be enrolled to undergo diffusion-weighted MRI brain
      imaging pre-procedure (optional) and post-procedure and neuropsychological testing pre- and
      post-procedure, and at 30 days of follow-up.
    
  